Simultaneously targeting lysosomal enzyme and KRAS-MAPK pathway eradicates pancreatic tumors in preclinical models

Published Date: 25 Apr 2025

Pancreatic cancer is a leading cause of cancer-related death, with a five-year survival rate of 13%. The high mortality is largely due to a lack of effective therapy options. In a recent paper published in Nature, researchers ...

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Belzutifan for Advanced Renal Cell Carcinoma is approved by the FDA.

2.

A Win for Molecularly Guided Therapy for Cancer of Unknown Primary

3.

Combination of significant weight gain and late motherhood greatly increases risk of breast cancer, study finds

4.

FDA Authorizes Three Different Uses for Injectable Antibiotic.

5.

Five new papers highlight cancer inequities, challenges and opportunities in South Asia


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot